Sign Up to like & get
recommendations!
1
Published in 2021 at "Journal of Heart and Lung Transplantation"
DOI: 10.1016/j.healun.2021.01.1289
Abstract: Purpose The REPLACE study showed that switching to riociguat (rio) can benefit pulmonary arterial hypertension (PAH) patients treated with phosphodiesterase type 5 inhibitors (PDE5i) but still at intermediate risk. Improvements to lower risk status with…
read more here.
Keywords:
assessment tools;
rio;
pde5i;
risk ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Circulation"
DOI: 10.1161/circ.142.suppl_3.15731
Abstract: Introduction: Heart failure (HF) remains a leading cause of death and indication for transplant in single ventricle congenital heart disease (SV). However, little is known regarding the molecular mechanisms leading to HF in SV. The…
read more here.
Keywords:
svnf;
mitochondrial function;
svhf;
pde5i ... See more keywords